Inhibition of EHMT2 resensitizes pancreatic cancer cells to GEM in vitro, and the combination of EHMT2 inhibitor and GEM can overcome drug resistance in animal models [18]. The gene discussed is EHMT2; the disease is familial pancreatic carcinoma.